Key Resources


TransCelerate’s Patient Experience Initiative tools are intended to provide more effective ways to engage with patients in the design and execution of clinical studies.

The Patient Protocol Engagement Toolkit (P-PET) facilitates the design of clinical studies with patient inputs.

The Study Participant Feedback Questionnaire (SPFQ) Toolkit is a set of questionnaires administered at the beginning, during and end of the study to improve studies by learning from patients.


Benefits for Patients:

  • Increased engagement through better communication and feedback processes
  • Increased understanding of the value in participating in clinical trials
  • Potential increase in the sense of altruism due to the confidence of knowing that their participation and feedback in trials may improve future study volunteers’ experiences
  • Potential decrease in the burden of participating in clinical trials

Benefits for Sponsors, Sites and Investigators:

  • Potential improvement in patient recruitment, retention, and adherence within clinical trials
  • Potential reduction in long term costs through more effective patient engagement


Available Assets

The following assets are now available:

Patient Protocol Engagement Toolkit (P-PET): The P-PET provides tools and resources to use in engaging patient advisors during protocol development with the goal to improve patient experience and reduce patient burden as a study participant. The P-PET can be utilized by sponsors to partner with patient advisors in creating patient-centric clinical studies.

Study Participant Feedback Questionnaire Toolkit (SPFQ)The SPFQ is a questionnaire for patients at the beginning, middle and end of a clinical study. The questionnaire results will help sponsors learn from patients so that they may improve trials.

Similar Initiatives

Patient Technology

The Patient Technology (PT) Initiative seeks to facilitate and accelerate the industry’s progression towards a future where patients have access to innovative technologies that enhance the patient experience and reduce patient burden in clinical trials.



The TransCelerate eLabels initiative will help the industry progress on the journey to digitally supported, patient-centric clinical supply chains.



The eConsent Initiative will create a common approach for the electronic consenting of patients using an array of digital elements and process efficiencies to increase insight into patients’ understanding, increase regulatory compliance, and reduce quality risks.

Translate »

Stay Connected to TransCelerate.